Developing Sphingosine-1-Phosphate (Spns2) Inhibitors for the Treatment of Multiple Sclerosis

Shrader, Christopher Wayne2024-03-012024-03-012024-02-29vt_gsexam:39500https://hdl.handle.net/10919/118217ETDenIn Copyrightsphingosine-1-phosphates1pspns2structure-activity relationship studyspinster homolog 2multiple sclerosisDeveloping Sphingosine-1-Phosphate (Spns2) Inhibitors for the Treatment of Multiple SclerosisDissertation